Global law firm Clifford Chance has advised general trading company Mitsui & Co on its deal with Ceva Santé Animale to establish joint venture Ceva Bussan Animal Health for an undisclosed amount.
Under the agreement, Mitsui transferred 60% of its shareholding in Bussan Animal Health to Ceva Santé Animale, a French multinational veterinary pharmaceutical company, and made an additional equity investment. The joint venture will be set up through Mitsui subsidiary Bussan Animal Health and the French giant’s Ceva Japan.
Clifford Chance advised Mitsui on all aspects of the transaction, including structuring the share purchase agreement and shareholders’ arrangement. Tokyo partner and head of the Japan antitrust team Masafumi Shikakura led the transaction team, which included partner Natsuko Sugihara, and senior associates Hiromu Suemasa and Yuki Hoshinaga.
Paris-based partner Laurent Schoenstein and counsel Alice Declercq also advised on the deal.
The joint venture is expected to strengthen collaboration between Mitsui and Ceva Santé Animale on broader global initiatives, including the development of new products and technologies, market expansion and the creation of long-term sustainable value in the animal health sector.
AloJapan.com